Example: Heart Attack

Search clinical trials for: Ritonavir

Total 1038 results

NCT01074931

Completed

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

Conditions: HIV-1 Infections
NCT01810887

Completed

A Phase 4 Study to Evaluate Pharmacokinetics and Safety of Darunavir Along With Ritonavir in Healthy Male Japanese Participants

Conditions: Healthy
NCT01700790

Terminated

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Conditions: AIDS; Tuberculosis
NCT02348177

Completed

Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

Conditions: Acquired Immunodeficiency Syndrome; Tuberculosis
NCT02034838

Completed

Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study

Conditions: HIV Infection
NCT01606722

Completed

Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy

Conditions: HIV-infection
NCT04261907

Not yet recruiting

Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection

Conditions: 2019-nCoV
NCT01237444

Completed

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.

Conditions: HIV Infection
NCT01172535

Completed

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines

Conditions: HIV
NCT00985543

Completed

Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.

Conditions: Acquired Immunodeficiency Syndrome
NCT02527707

Completed

Titrating-Dose of Lonafarnib in Combination With Ritonavir

Conditions: Chronic Delta Hepatitis
NCT04345276

Completed

Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection

Conditions: COVID-19
NCT02219503

Completed

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis

Conditions: Chronic Hepatitis C Infection; Compensated Cirrhosis
NCT03593954

Completed

A Study to Assess the Effect of Ritonavir on the Single-Dose Pharmacokinetics of JNJ-61393215 in Healthy Participants

Conditions: Healthy
NCT01009437

Completed

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Conditions: Breast Cancer
NCT01581853

Completed

Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily

Conditions: HIV
NCT02183441

Completed

Bioavailability of BI 1356 After Co-administration With Ritonavir Compared to the Bioavailability of BI 1356 Alone in Healthy Male Volunteers

Conditions: Healthy
NCT02503462

Terminated

Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals

Conditions: AIDS-related Dementia Complex
NCT02476617

Completed

Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults

Conditions: Chronic Hepatitis C; Hepatitis C (HCV); Hepatitis C Genotype 1a
NCT01891851

Completed

A Study of Drug-drug Interaction Between Ritonavir and TMC435350 in Healthy Volunteers

Conditions: Healthy
NCT02223351

Completed

Drug-Drug Interaction Study: ASP2151 and Ritonavir

Conditions: Healthy
NCT03485846

Completed

Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b

Conditions: Chronic Hepatitis C Genotype 1b
NCT01335698

Completed

Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients

Conditions: HIV
NCT01672983

Completed

A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection

Conditions: Chronic Hepatitis C Infection
NCT04321174

Recruiting

COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir

Conditions: Coronavirus Infections; Post-exposure Prophylaxis